Antipodes Emerging Market Debt Fund

The Antipodes Emerging Market Debt Fund is managed using a disciplined value-oriented approach supported by intensive, on-the-ground bottom-up fundamental research resulting in a concentrated portfolio of fixed interest securities issued by companies in emerging markets, which, in the view of the Investment Manager, are undervalued, on either an absolute or a relative basis, have the potential to generate regular income and have the potential for some capital appreciation.

This product is intended for use as a satellite or minor allocation for a consumer who is seeking regular income and some long-term capital growth and has a medium/high risk and return profile for that portion of their investment portfolio. It is likely to be consistent with the financial situation and needs of a consumer with a 3 year investment timeframe and who is unlikely to need to withdraw their money on less than one week’s notice.

Net performance

Net performance

Returns greater than 1 year are annualised. Past performance is no indication of future performance. 1Inception is 31 August 2011.

The Fund was previously known as the Antipodes Asia Income Fund and Premium Asia Income Fund. Antipodes Partners Limited has appointed Value Partners under a sub-investment manager agreement to undertake portfolio management of the Fund. Value Partners have been the Investment Manager of this Fund since its inception.

Performance chart

Cumulative performance (over selected time horizon)

Antipodes Emerging Market Debt Fund

Returns greater than 1 year are annualised. Past performance is no indication of future performance. Calculations are based on exit price with distributions reinvested.

Key facts

wdt_ID Title Detail
1 Investment manager Antipodes Partners Limited
21 Sub investment manager Value Partners
22 Responsible entity Maple-Brown Abbott Limited
23 Strategy Emerging Markets Fixed Interest
24 Investment objective The Fund aims to generate regular income with some long-term capital growth. Benchmark.
26 Suggested minimum investment period 3 to 5 years
27 Risk Medium
28 Portfolio Allocation1 20-100% Asian, Middle Eastern and Commonwealth Independent States (CIS) fixed interest securities
0-35% Other Emerging Markets fixed interest securities, not including Asia, Middle East and CIS
0-80% Cash
29 Registration Australia
30 Dealing frequency & cut-off Daily / 2pm Sydney
31 Distribution frequency Quarterly
32 Minimum initial investment A$25,000
33 Minimum additional investment A$10,000
34 Strategy inception date Aug-11
36 APIR MAQ0782AU
37 ARSN 151 270 423
40 Bloomberg code MAQ0782:AU
41 ISIN AU60MAQ07821
1The portfolio allocation ranges provided are indicative only. The Fund will be rebalanced within a reasonable period of time should the exposure move outside these ranges.
Unit price history

Unit price history

Distribution history

Distribution history

Portfolio profile as at 31st December 2025
Top 10 holdings (%)
Sector exposure (%)2
Portfolio characteristics and product composition (%)
Regional exposure (%)1, 3
1 Where possible, regions, countries and currencies classified on a look through basis. 2 GICS Classification. 3 Antipodes Partners classification.
Monthly updates
For historical reports, please contact the Antipodes team
For historical reports, please contact the Antipodes team
Invest

If you are applying using paper application forms, the minimum investment in the Antipodes Emerging Market Debt Fund is $25,000 for new investors and $10,000 for existing investors.

Who may invest in the fund

This fund is open to investors from Australia and New Zealand.

Important information

It is a legal requirement to download and read the Product Disclosure Statement before proceeding and we recommend that you consult a licensed financial advisor before making investment decisions.

Download Product Disclosure Statement (PDS).
Download Target Market Determination (TMD).

Apply online

The application below allows you to invest in the Antipodes Emerging Market Debt Fund.

If you are applying using paper application forms, the minimum investment in the Antipodes Emerging Market Debt Fund is $25,000 for new investors and $10,000 for existing investors.

Apply online

Apply via a paper form

Purchase, top-up or sell a managed fund investment the familiar way.

  1. Download an application form here
  2. Complete the application form & sign
  3. Provide certified copies of your identity to verify your identity
  4. Email service@pinnacleinvestment.com

Download an application form

Check out our investing tools
Our latest insights
Invest online now

Ratings

The Antipodes Emerging Market Debt Fund has been rated “Investment Grade” by Lonsec Research and “Superior” by SQM Research.

Important information

This information has been prepared by Antipodes Partners Limited (‘Antipodes’) (ABN 29 602 042 035, AFSL 481 580) as the Investment manager of the Antipodes Emerging Market Debt Fund (ARSN 151 270 423 ) (‘Fund’). Maple-Brown Abbott Limited (“MBAL”) (ABN 73 001 208 564, AFSL 237296), is the Responsible Entity for the Antipodes Antipodes Emerging Market Debt Fund Fund.  MBAL is a subsidiary of Antipodes Partners Limited. This report contains general information only, and does not take into account your investment objectives, financial situation or specific needs. Before making any investment decision, you should seek independent financial advice. This document does not constitute an offer or solicitation by anyone in any jurisdiction. Past performance is not a reliable indicator of future performance. Neither MBA, nor any of its related parties, directors or employees, make any representation or give any guarantee as to the return of capital, performance, any specific rate of return, or the taxation consequences of, any investment. 

Any views expressed on individual stocks or other investments, or any forecasts or estimates, are not a recommendation to buy, sell or hold, they are point in time views and may be based on certain assumptions and qualifications not set out in part or in full in this document. Individual stocks  referred to  may or may not be currently held by the Fund. Information derived from sources is believed to be accurate, however such information has not been independently verified and may be subject to assumptions and qualifications not described in this document. To the extent permitted by law, neither MBA, nor any of its related parties, directors or employees, make any representation or warranty as to the accuracy, completeness, reasonableness or reliability of this information, or accept liability or responsibility for any losses, whether direct, indirect or consequential, relating to, or arising from, the use or reliance on this information.  Before making a decision whether to acquire, or to continue to hold an investment in the Fund, investors should obtain and consider the current PDS and Target Market Determination (TMD) or any other relevant disclosure document. For the Fund, the PDS, AIB and TMD are available at https://antipodes.com or by calling 1300 097 995. 

The Lonsec Rating (assigned as follows: Antipodes Emerging Market Debt Fund – December 2024) presented in this document are published by Lonsec Research presented in this document are published by Lonsec Research Pty Ltd ABN 11 151 658 561 AFSL 421445. The Ratings are limited to “General Advice” (as defined in the Corporations Act 2001 (Cth)) and based solely on consideration of the investment merits of the financial products. Past performance information is for illustrative purposes only and is not indicative of future performance. They are not a recommendation to purchase, sell or hold Antipodes products, and you should seek independent financial advice before investing in these products. The Ratings are subject to change without notice and Lonsec assumes no obligation to update the relevant documents following publication. Lonsec receives a fee from the Fund Manager for researching the products using comprehensive and objective criteria. For further information regarding Lonsec’s Ratings methodology, please refer to our website at https://www.lonsec.com.au/.
 

The rating contained on this page is issued by SQM Research Pty Ltd ABN 93 122 592 036AFSL 421913. SQM Research is an investment research firm that undertakes research on investment products exclusively for its wholesale clients, utilising a proprietary review and star rating system. The SQM Research star rating system is of a general nature and does not take into account the particular circumstances or needs of any specific person. The rating may be subject to change at any time. Only licensed financial advisers may use the SQM Research star rating system in determining whether an investment is appropriate to a person’s particular circumstances or needs. You should read the product disclosure statement and consult a licensed financial adviser before making an investment decision in relation to this investment product. SQM Research receives a fee from the Fund Manager for the research and rating of the managed investment scheme.

Now available on the ASX: the Antipodes Global SMID Active ETF (ASX:MIDS)

Find out more
X

By clicking I agree below, you confirm that you are an Australian resident, or will only access Fund Information as a unitholder in a Fund issued by Pinnacle Fund Services Limited, and you accept all of the Terms of Use of this website, which may be found here.

By clicking I agree below, you confirm that you are a New Zealand resident, or will only access Fund Information as a unitholder in a Fund issued by Pinnacle Fund Services Limited or Fund Rock NZ Limited, and you accept all of the Terms of Use of this website, which may be found here.

By clicking I agree below, you confirm that you are a qualified / professional investor or equivalent in the United Kingdom or Europe. You also confirm that by accessing this website, you will not contravene, or cause Antipodes or any of its affiliates to contravene, any law that seeks to regulate financial promotions both in the country of your residence and in the country in which you are viewing this webpage and you accept all of the Terms of Use of this website, which may be found here.

By clicking I agree below, you confirm that you are a qualified / professional investor or equivalent in the United States of America. You also confirm that by accessing this website, you will not contravene, or cause Antipodes or any of its affiliates to contravene, any law that seeks to regulate financial promotions both in the country of your residence and in the country in which you are viewing this webpage and you accept all of the Terms of Use of this website, which may be found here.

By clicking I agree below, you confirm that you are a qualified / professional investor or equivalent in the relevant jurisdiction where the vehicle is permitted to be marketed to. You also confirm that by accessing this website, you will not contravene, or cause Antipodes or any of its affiliates to contravene, any law that seeks to regulate financial promotions both in the country of your residence and in the country in which you are viewing this webpage and you accept all of the Terms of Use of this website, which may be found here.

I agree